The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
Hemolytic Uremic Syndrome (HUS) associated with Shiga-toxigenic <i>Escherichia coli</i> (STEC) infections is the principal cause of acute renal injury in pediatric age groups. Shiga toxin type 2 (Stx2) has in vitro cytotoxic effects on kidney cells, including human glomerular endothelial...
Enregistré dans:
| Auteurs principaux: | Daniela Luz, Fernando D. Gómez, Raíssa L. Ferreira, Bruna S. Melo, Beatriz E. C. Guth, Wagner Quintilio, Ana Maria Moro, Agostina Presta, Flavia Sacerdoti, Cristina Ibarra, Gang Chen, Sachdev S. Sidhu, María Marta Amaral, Roxane M. F. Piazza |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ee4e3434a60a4688a020358caa726ff9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by <named-content content-type="genus-species">Enterobacter cloacae</named-content> and Their Use in Analysis of Human Serum
par: Craig Skinner, et autres
Publié: (2016) - Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Agritourism and Kidding Season: A Large Outbreak of Human Shiga Toxin-Producing Escherichia coli O157 (STEC O157) Infections Linked to a Goat Dairy Farm—Connecticut, 2016
par: Megin C. Nichols, et autres
Publié: (2021) -
Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
par: Valdés A,María del Pilar, et autres
Publié: (2006) -
Human antibodies
Publié: (1997)